| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $83.5M | — | +117.4% |
| Cost of Revenue | $25.1M | — | +37.9% |
| Gross Profit | $58.4M | — | +189.0% |
| R&D Expense | $13.0M | — | +35.6% |
| SG&A Expense | $35.8M | — | +53.8% |
| Operating Income | $9.6M | — | +176.2% |
| Pre-tax Income | $5.6M | — | +137.5% |
| Income Tax | -$129K | — | — |
| Net Income | $5.7M | — | +138.3% |
| EPS (Basic) | $0.14 | — | +109.5% |
| EPS (Diluted) | $0.10 | — | +106.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $195.2M | — | — |
| Accounts Receivable | $34.6M | — | — |
| Inventory | $17.4M | — | — |
| Current Assets | $251.7M | — | — |
| Total Assets | $327.5M | — | — |
| Current Liabilities | $40.8M | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $13.8M | — | — |
| Capital Expenditures | $7.3M | — | — |
| Investing Cash Flow | -$7.3M | — | — |
| Financing Cash Flow | -$2.8M | — | — |
| Free Cash Flow | $6.5M | — | — |
| Long-term Debt |
| $55.0M |
| — |
| — |
| Total Liabilities | $147.6M | — | — |
| Stockholders' Equity | -$239.5M | +4.3% | +1.4% |